[go: up one dir, main page]

PE36298A1 - Compuestos 1,4-dihidropiridina - Google Patents

Compuestos 1,4-dihidropiridina

Info

Publication number
PE36298A1
PE36298A1 PE1997000085A PE00008597A PE36298A1 PE 36298 A1 PE36298 A1 PE 36298A1 PE 1997000085 A PE1997000085 A PE 1997000085A PE 00008597 A PE00008597 A PE 00008597A PE 36298 A1 PE36298 A1 PE 36298A1
Authority
PE
Peru
Prior art keywords
compounds
ilo
hidroxi
oct
dihydropyridine
Prior art date
Application number
PE1997000085A
Other languages
English (en)
Inventor
Takamufi Ikeda
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of PE36298A1 publication Critical patent/PE36298A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

SE REFIEREN A COMPUESTOS DE FORMULA (I), EN DONDE: A1 Y A2 SON PREFERENTEMENTE CLORO; "X" ES CO, S(O)2 o S(O)-(CH2)n, DONDE EL ATOMO DE S ESTA UNIDO DIRECTAMENTE AL FENILO Y n ES 0, 1 o 2; R1 SON PRERENTEMENTE 8-METIL-8-AZABICICLO[3.2.1]OCT-3-ILO, QUINUCLIDIN-3-ILO, [1-(HIDROXI)CICLOPENTIL]ETILO o (3-HIDROXI o 3-OXO)-BICICLO[3.3.0]OCT-7-ILO. ESTOS COMPUESTOS SON ANTAGONISTAS NO PEPTIDICOS DE LA BRADICININA, SIENDO UTILES EN EL TRATAMIENTO DE LA INFLAMACION, DE LA ENFERMEDAD CARDIOVASCULAR, DEL DOLOR O DEL CATARRO COMUN, ENTRE OTROS
PE1997000085A 1996-02-19 1997-02-10 Compuestos 1,4-dihidropiridina PE36298A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IB9600132 1996-02-19

Publications (1)

Publication Number Publication Date
PE36298A1 true PE36298A1 (es) 1998-07-18

Family

ID=11004406

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1997000085A PE36298A1 (es) 1996-02-19 1997-02-10 Compuestos 1,4-dihidropiridina

Country Status (34)

Country Link
US (1) US6131226A (es)
EP (1) EP0882044B1 (es)
JP (1) JP3167335B2 (es)
KR (1) KR19990082678A (es)
CN (1) CN1211251A (es)
AR (1) AR005841A1 (es)
AT (1) ATE220676T1 (es)
AU (1) AU1396497A (es)
BG (1) BG102678A (es)
BR (1) BR9707568A (es)
CA (1) CA2245857C (es)
CO (1) CO4650041A1 (es)
CZ (1) CZ258698A3 (es)
DE (1) DE69714019T2 (es)
DK (1) DK0882044T3 (es)
ES (1) ES2177921T3 (es)
HN (1) HN1997000013A (es)
HR (1) HRP970094A2 (es)
HU (1) HUP9902810A3 (es)
ID (1) ID16434A (es)
IL (1) IL124867A0 (es)
IS (1) IS4783A (es)
MA (1) MA26419A1 (es)
NO (1) NO983776D0 (es)
NZ (1) NZ325455A (es)
OA (1) OA10712A (es)
PE (1) PE36298A1 (es)
PL (1) PL328514A1 (es)
PT (1) PT882044E (es)
SI (1) SI0882044T1 (es)
TN (1) TNSN97037A1 (es)
TR (1) TR199801593T2 (es)
WO (1) WO1997030048A1 (es)
ZA (1) ZA971357B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11106375A (ja) * 1997-08-18 1999-04-20 Pfizer Pharmaceut Inc ブラジキニンアンタゴニストとしての光学的に活性な１，４−ジヒドロピリジン化合物
EP1110962A1 (en) * 1999-12-10 2001-06-27 Pfizer Inc. Process for preparing 1,4-dihydropyridine compounds
US6653313B2 (en) * 2000-08-10 2003-11-25 Warner-Lambert Company Llc 1,4-dihydropyridine compounds as bradykinin antagonists
GB0427281D0 (en) * 2004-12-14 2005-01-12 3M Innovative Properties Co Methods of providing medicinal metal components having through holes

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5120750A (en) * 1989-01-17 1992-06-09 Synphar Laboratories, Inc. Generation of 1,4-dihydropyridine derivatives
WO1996006083A1 (en) * 1994-08-24 1996-02-29 Pfizer Pharmaceuticals Inc. 2-(piperazinyl-1-carbonylmethyl)-1,4-dihydropyridines as bradykinin antagonists
MX9701245A (es) * 1996-02-19 1998-04-30 Pfizer Compuestos de 1,4 dihidropiridina.

Also Published As

Publication number Publication date
NO983776L (no) 1998-08-18
EP0882044A1 (en) 1998-12-09
CA2245857A1 (en) 1997-08-21
ES2177921T3 (es) 2002-12-16
OA10712A (en) 2001-06-04
ZA971357B (en) 1998-08-18
PT882044E (pt) 2002-11-29
IS4783A (is) 1998-06-25
DK0882044T3 (da) 2002-09-02
MA26419A1 (fr) 2004-12-20
KR19990082678A (ko) 1999-11-25
NO983776D0 (no) 1998-08-18
ATE220676T1 (de) 2002-08-15
BG102678A (en) 1999-04-30
HN1997000013A (es) 1997-06-26
AU1396497A (en) 1997-09-02
AR005841A1 (es) 1999-07-14
HUP9902810A3 (en) 2000-09-28
US6131226A (en) 2000-10-17
NZ325455A (en) 1999-07-29
SI0882044T1 (en) 2002-10-31
CA2245857C (en) 2002-10-01
TR199801593T2 (xx) 1999-12-21
JP3167335B2 (ja) 2001-05-21
IL124867A0 (en) 1999-01-26
HRP970094A2 (en) 1998-06-30
DE69714019D1 (de) 2002-08-22
CO4650041A1 (es) 1998-09-03
CN1211251A (zh) 1999-03-17
HUP9902810A2 (hu) 2000-05-28
TNSN97037A1 (fr) 2005-03-15
DE69714019T2 (de) 2002-11-14
WO1997030048A1 (en) 1997-08-21
CZ258698A3 (cs) 1999-06-16
BR9707568A (pt) 1999-07-27
PL328514A1 (en) 1999-02-01
ID16434A (id) 1997-09-25
EP0882044B1 (en) 2002-07-17
JPH11507949A (ja) 1999-07-13

Similar Documents

Publication Publication Date Title
MX9701679A (es) Derivados de piperidina como antagonistas de la neuroquinina.
DK0531410T3 (da) (+)-alfa-(2,3-Demethoxyphenyl)-1-(2-(4-fluorphenyl)ethyl)-4-piperidinmethanol
DE69627228D1 (de) Biokompatible medizinische Elektrodenleitung
SE9604786D0 (sv) New compounds
EP0844882A4 (en) REGULATORY COMPOSITIONS OF APPETITE
ATE360019T1 (de) Substituierte 1,3-oxathiolane mit antviralen eigenschaften
PE29798A1 (es) Acetidinas
DE69814394D1 (de) Verwendung von levobupivacain
DK1077941T3 (da) Forbindelser med væksthormonfrigörende egenskaber
DE59509395D1 (de) Verwendung von Lactamverbindungen als pharmazeutische Wirkstoffe
EA199900385A1 (ru) Соединения 1-арил-2-ациламиноэтана и их применение в качестве антагонистов нейрокинина, в частности нейрокинина 1
ES2110260T3 (es) Androstenonas.
DE69330272D1 (de) 4-imidomethyl-1-[2&#39;-phenyl-2-oxoethyl]-piperidine als serotonin-5ht2-antagonisten, ihre herstellung und therapeutische anwendung
PE36298A1 (es) Compuestos 1,4-dihidropiridina
ATE243036T1 (de) Levobupivacain und dessen verwendung als anästhetikum bei schwangeren frauen
MXPA04004826A (es) Antagonista del receptor de quimioquinas y metodos para su uso.
ES2097025T3 (es) Oxindol 1-(n-(alcoxicarbonil))carboxamidas y 1-(n-carboxamido)carboxamidas como agentes antiinflamatorios.
MX9300409A (es) Hexahidroazepinonas y tetrahidrobenzoazepinonas sustituidas.
BR9703240A (pt) Estabilização de peróxidos orgânicos com compostos b-dicarbonila ou &amp;-dicetona cíclica
AR247200A1 (es) Procedimiento para preparar una nueva clase de agentes medicinales piperidinilicos, utiles como agentes antitromboticos y como antagonistas de los receptores de 5ht2 de serotonina.
FR2695556B1 (fr) Composition biologique contenant des EGF destinée à réguler la croissance cellulaire.
IT9021785A0 (it) Cilindro di regolazione dell&#39;infessione
ATE262307T1 (de) Verwendung von goldlegierungen für konstruktionselemente in der dentaltechnik
NO995847L (no) Salter av optisk aktivt sulfoksydderivat
ATE124398T1 (de) 1,3,4-trisubstituierte piperidin-derivate, ihre herstellung und verwendung.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal